Drug Type Shared antigen vaccine, Therapeutic vaccine |
Synonyms IO 101, IO101 |
Target |
Mechanism IDO1 inhibitors(Indoleamine 2,3-dioxygenase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Phase 2 | DK | 26 Apr 2012 | |
Non-Small Cell Lung Cancer | Phase 1 | DK | - | - |
Non-Small Cell Lung Cancer | Phase 1 | - | - | |
Non-Small Cell Lung Cancer | Phase 1 | - | - |